StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$5.83−0.18 (-3.08%)

Close on Nov 18, 2026Market cap $108.99MP/E –Yield –

Trinity Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$5.93M. The highest annual figure on record is $23.76M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.93M–
FY2024Dec 31, 2024-$4.19M–
FY2023Dec 31, 2023-$11.56M–
FY2022Dec 31, 2022-$921.00K-107.0%
FY2021Dec 31, 2021$13.24M-44.3%
FY2020Dec 31, 2020$23.76M+338.5%
FY2019Dec 31, 2019$5.42M-25.1%
FY2018Dec 31, 2018$7.23M-21.8%
FY2017Dec 31, 2017$9.25M-9.6%
FY2016Dec 31, 2016$10.23M-22.3%
FY2015Dec 31, 2015$13.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 2018$1.74M–
Q2 FY2017Jun 30, 2017$3.37M–

More Trinity Biotech figures

See a number that looks wrong?